Bioline RX Ltd Sponsored ADR (BLRX) has released an update.
BioLineRx Ltd. has announced its Annual General Meeting for shareholders to be held on October 1, 2024, at the company’s offices in Modi’in, Israel. Shareholders will vote on key issues, including the re-election of Class I directors, granting of options to directors, an increase in share capital, and the reappointment of Kesselman & Kesselman as auditors. Management will also review the company’s 2023 financial statements and shareholders are encouraged to vote in person or by proxy.
For further insights into BLRX stock, check out TipRanks’ Stock Analysis page.